TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2015

Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy.

Yoshimasa Kosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.